Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-10 Purchase | 2023-03-10 1:34 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 10,000 | $3.37 | $33,700 | 6,021,873 (Direct) | View |
| 2023-02-27 Purchase | 2023-02-27 11:39 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $3.98 | $79,600 | 6,011,873 (Direct) | View |
| 2023-02-15 Purchase | 2023-02-15 10:47 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $3.86 | $77,200 | 5,991,873 (Direct) | View |
| 2023-01-31 Purchase | 2023-01-31 10:14 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $4.05 | $81,000 | 5,471,873 (Direct) | View |
| 2023-01-24 Purchase | 2023-01-24 10:49 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 20,000 | $4.19 | $83,800 | 5,451,873 (Direct) | View |
| 2022-11-22 Sale | 2022-11-25 4:41 pm | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 24,500 | $4.233 | $103,708 | 1,060,414 (Direct) | View |
| 2022-11-18 Sale | 2022-11-22 4:15 pm | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 22,261 | $4.3568 | $96,986 | 1,084,914 (Direct) | View |
| 2022-11-08 Purchase | 2022-11-10 4:44 pm | Compass Therapeutics Inc. | CMPX | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC OrbiMed Genesis GP LLC Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-11-08 Purchase | 2022-11-10 4:38 pm | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 402,000 | $3.21 | $1,290,420 | 18,791,422 (Indirect) | View |
| 2022-09-28 Purchase | 2022-09-28 4:45 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 10,000 | $2.32 | $23,200 | 5,431,873 (Direct) | View |
| 2022-09-26 Purchase | 2022-09-27 09:47 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.27 | $34,050 | 5,421,873 (Direct) | View |
| 2022-09-07 Purchase | 2022-09-08 10:12 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $3.03 | $45,450 | 5,406,873 (Direct) | View |
| 2022-09-01 Purchase | 2022-09-01 2:37 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.83 | $42,450 | 5,391,873 (Direct) | View |
| 2022-08-17 Purchase | 2022-08-17 4:06 pm | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $3.05 | $45,750 | 5,376,873 (Direct) | View |
| 2022-08-10 Purchase | 2022-08-10 10:51 am | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 15,000 | $2.64 | $39,600 | 5,361,873 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-13 Option Award | 2024-08-14 08:49 am | N/A 2034-08-13 | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2024-08-09 4:07 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Anderman Jonathan Sr VP, Gen Counsel & Corp Sec | 0 | $0 | 426,000 (Direct) | View |
| 2024-03-08 Option Award | 2024-03-11 10:12 am | N/A 2034-03-07 | Compass Therapeutics Inc. | CMPX | Boylan James P Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:03 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:03 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:02 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:01 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-09 Option Award | 2024-02-14 12:00 pm | N/A 2034-02-08 | Compass Therapeutics Inc. | CMPX | Ferneau Philip Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2024-02-08 Tax Withholding | 2024-02-09 12:50 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered CHIEF EXECUTIVE OFFICER | 49,198 | $1.45 | 3,124,426 (Direct) | View |
| 2024-02-08 Tax Withholding | 2024-02-09 12:49 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. PRESIDENT | 44,782 | $1.45 | 6,570,566 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-10 10:31 am | N/A 2034-01-08 | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer | 1,753,125 | $0 | 4,926,749 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-10 10:31 am | N/A N/A | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Executive Officer | 1,753,125 | $1.93 | 4,926,749 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-10 10:31 am | N/A 2034-01-08 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. President of R&D | 637,500 | $0 | 7,252,848 (Direct) | View |
| 2024-01-09 Option Award | 2024-01-10 10:31 am | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. President of R&D | 637,500 | $1.93 | 7,252,848 (Direct) | View |
| 2023-11-17 Tax Withholding | 2023-11-21 2:10 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 64,415 | $1.5 | 1,420,499 (Direct) | View |
| 2023-11-17 Tax Withholding | 2023-11-21 2:08 pm | N/A N/A | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 44,025 | $1.5 | 5,977,848 (Direct) | View |
| 2023-04-21 Option Award | 2023-04-24 4:32 pm | N/A 2033-04-20 | Compass Therapeutics Inc. | CMPX | LINDAHL RICHARD S Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-10 4:01 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | WURZER DAVID M Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 4:31 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | Chiniara Ellen Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 4:31 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | GRAY MARY ANN Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 4:28 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | Ferneau Philip Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 4:28 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | GORDON CARL L Director 10% Owner | 60,000 | $0 | 60,000 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 4:23 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | Schuetz Thomas J. CHIEF EXECUTIVE OFFICER | 1,200,000 | $0 | 6,671,873 (Direct) | View |
| 2023-02-08 Option Award | 2023-02-09 3:03 pm | N/A 2033-02-07 | Compass Therapeutics Inc. | CMPX | Bisker-Leib Vered Chief Operating Officer | 1,000,000 | $0 | 2,084,914 (Direct) | View |